151 related articles for article (PubMed ID: 36983080)
21. Metabolic rewiring in drug resistant cells exhibit higher OXPHOS and fatty acids as preferred major source to cellular energetics.
Salunkhe S; Mishra SV; Ghorai A; Hole A; Chandrani P; Dutt A; Chilakapati M; Dutt S
Biochim Biophys Acta Bioenerg; 2020 Dec; 1861(12):148300. PubMed ID: 32858000
[TBL] [Abstract][Full Text] [Related]
22. Drug responsiveness of leukemic cells detected in vitro at diagnosis correlates with therapy response and survival in patients with acute myeloid leukemia.
Kolesnikova MA; Sen'kova AV; Pospelova TI; Zenkova MA
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1362. PubMed ID: 33675187
[TBL] [Abstract][Full Text] [Related]
23. miR-638 regulates differentiation and proliferation in leukemic cells by targeting cyclin-dependent kinase 2.
Lin Y; Li D; Liang Q; Liu S; Zuo X; Li L; Sun X; Li W; Guo M; Huang Z
J Biol Chem; 2015 Jan; 290(3):1818-28. PubMed ID: 25451924
[TBL] [Abstract][Full Text] [Related]
24. Dual mTORC2/mTORC1 targeting results in potent suppressive effects on acute myeloid leukemia (AML) progenitors.
Altman JK; Sassano A; Kaur S; Glaser H; Kroczynska B; Redig AJ; Russo S; Barr S; Platanias LC
Clin Cancer Res; 2011 Jul; 17(13):4378-88. PubMed ID: 21415215
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells.
Jones CL; Stevens BM; D'Alessandro A; Reisz JA; Culp-Hill R; Nemkov T; Pei S; Khan N; Adane B; Ye H; Krug A; Reinhold D; Smith C; DeGregori J; Pollyea DA; Jordan CT
Cancer Cell; 2018 Nov; 34(5):724-740.e4. PubMed ID: 30423294
[TBL] [Abstract][Full Text] [Related]
26. Dielectrophoretic Microfluidic Chip Enables Single-Cell Measurements for Multidrug Resistance in Heterogeneous Acute Myeloid Leukemia Patient Samples.
Khamenehfar A; Gandhi MK; Chen Y; Hogge DE; Li PC
Anal Chem; 2016 Jun; 88(11):5680-8. PubMed ID: 27149245
[TBL] [Abstract][Full Text] [Related]
27. The metabolic reprogramming in acute myeloid leukemia patients depends on their genotype and is a prognostic marker.
Lo Presti C; Fauvelle F; Jacob MC; Mondet J; Mossuz P
Blood Adv; 2021 Jan; 5(1):156-166. PubMed ID: 33570627
[TBL] [Abstract][Full Text] [Related]
28. Dysregulation of SIRT3 SUMOylation Confers AML Chemoresistance via Controlling HES1-Dependent Fatty Acid Oxidation.
Zhang Y; Shen Y; Wei W; Wang W; Jiang D; Ren Y; Peng Z; Fan Q; Cheng J; Ma J
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955415
[TBL] [Abstract][Full Text] [Related]
29. High proportion of leukemic stem cells at diagnosis is correlated with unfavorable prognosis in childhood acute myeloid leukemia.
Witte KE; Ahlers J; Schäfer I; André M; Kerst G; Scheel-Walter HG; Schwarze CP; Pfeiffer M; Lang P; Handgretinger R; Ebinger M
Pediatr Hematol Oncol; 2011 Mar; 28(2):91-9. PubMed ID: 21214408
[TBL] [Abstract][Full Text] [Related]
30. The plasma lipidome in acute myeloid leukemia at diagnosis in relation to clinical disease features.
Pabst T; Kortz L; Fiedler GM; Ceglarek U; Idle JR; Beyoğlu D
BBA Clin; 2017 Jun; 7():105-114. PubMed ID: 28331812
[TBL] [Abstract][Full Text] [Related]
31. Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia.
Del Poeta G; Bruno A; Del Principe MI; Venditti A; Maurillo L; Buccisano F; Stasi R; Neri B; Luciano F; Siniscalchi A; de Fabritiis P; Amadori S
Curr Cancer Drug Targets; 2008 May; 8(3):207-22. PubMed ID: 18473734
[TBL] [Abstract][Full Text] [Related]
32. Targeting the leukemia cell metabolism by the CPT1a inhibition: functional preclinical effects in leukemias.
Ricciardi MR; Mirabilii S; Allegretti M; Licchetta R; Calarco A; Torrisi MR; Foà R; Nicolai R; Peluso G; Tafuri A
Blood; 2015 Oct; 126(16):1925-9. PubMed ID: 26276667
[TBL] [Abstract][Full Text] [Related]
33. Mesenchymal stromal cells contribute to quiescence of therapy-resistant leukemic cells in acute myeloid leukemia.
Wang W; Bochtler T; Wuchter P; Manta L; He H; Eckstein V; Ho AD; Lutz C
Eur J Haematol; 2017 Nov; 99(5):392-398. PubMed ID: 28800175
[TBL] [Abstract][Full Text] [Related]
34. Malignant progenitors from patients with acute myelogenous leukemia are sensitive to a diphtheria toxin-granulocyte-macrophage colony-stimulating factor fusion protein.
Hogge DE; Willman CL; Kreitman RJ; Berger M; Hall PD; Kopecky KJ; McLain C; Tagge EP; Eaves CJ; Frankel AE
Blood; 1998 Jul; 92(2):589-95. PubMed ID: 9657759
[TBL] [Abstract][Full Text] [Related]
35. Targeting leukemia's "fatty tooth".
Samudio I; Konopleva M
Blood; 2015 Oct; 126(16):1874-5. PubMed ID: 26472736
[TBL] [Abstract][Full Text] [Related]
36. CGRP Signaling via CALCRL Increases Chemotherapy Resistance and Stem Cell Properties in Acute Myeloid Leukemia.
Gluexam T; Grandits AM; Schlerka A; Nguyen CH; Etzler J; Finkes T; Fuchs M; Scheid C; Heller G; Hackl H; Harrer N; Sill H; Koller E; Stoiber D; Sommergruber W; Wieser R
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31756985
[TBL] [Abstract][Full Text] [Related]
37. Growth differentiation factor 15 contributes to marrow adipocyte remodeling in response to the growth of leukemic cells.
Lu W; Wan Y; Li Z; Zhu B; Yin C; Liu H; Yang S; Zhai Y; Yu Y; Wei Y; Shi J
J Exp Clin Cancer Res; 2018 Mar; 37(1):66. PubMed ID: 29566722
[TBL] [Abstract][Full Text] [Related]
38. High Expression of ACOT2 Predicts Worse Overall Survival and Abnormal Lipid Metabolism: A Potential Target for Acute Myeloid Leukemia.
Yin X; Lyu C; Li Z; Wang Q; Ding Y; Wang Y; Qiu Y; Cui S; Guo D; Xu R
J Healthc Eng; 2022; 2022():2669114. PubMed ID: 36193167
[TBL] [Abstract][Full Text] [Related]
39. A novel fatty acid metabolism-related signature identifies features of the tumor microenvironment and predicts clinical outcome in acute myeloid leukemia.
Zhang HB; Sun ZK; Zhong FM; Yao FY; Liu J; Zhang J; Zhang N; Lin J; Li SQ; Li MY; Jiang JY; Cheng Y; Xu S; Cheng XX; Huang B; Wang XZ
Lipids Health Dis; 2022 Aug; 21(1):79. PubMed ID: 36002858
[TBL] [Abstract][Full Text] [Related]
40. The Role of Mitochondrial Fat Oxidation in Cancer Cell Proliferation and Survival.
De Oliveira MP; Liesa M
Cells; 2020 Dec; 9(12):. PubMed ID: 33291682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
